Clinical trial NCT06527586: A Study to Evaluate the Safety and Efficacy of Eye Secret UV Aspheric Silicone Soft (Hydrophilic) 1Day Color Contact Lens
Official title: A Study to Evaluate the Safety and Efficacy of Eye Secret UV Aspheric Silicone Soft (Hydrophilic) 1Day Color Contact Lens
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Myopia
Lead sponsor: Yung Sheng Optical Co., Ltd.
Sponsor class: INDUSTRY
First posted: 2024-07-30
Enrollment: 131
Sex: ALL
Minimum age (years): 20
Maximum age (years): 25
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This was a prospective, randomized, open label, parallel, active-controlled clinical study to assess the safety and efficacy of Silicone Color Contact Lens for vision correction.


Eligibility criteria: Inclusion Criteria:

1. Age from 20 to 65.
2. Subject with -1.00 to -10.00 D myopia, less than 1.00 D astigmatism.
3. Subjects must be correctable through spherocylindrical refraction and with soft contact lenses to 0 Log MAR (distance) or better in each eye.
4. Willing to comply with all study procedures and be available for the study duration.
5. Provide signed and dated informed consent form.

Exclusion Criteria:

1. Subjects have a history of allergies that contraindicate contact lens wear.
2. Subjects have other active ocular or systemic diseases such as, but not limited to anterior uveitis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermas, keratoconus or diabetes.
3. Subjects have medications that would contraindicate contact lens wear.
4. Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next 3 months.
5. Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
6. Any active participation in any contact lens or lens care product clinical trial within seven days prior to this study.
7. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
8. Subject has a known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates or fungal infections.
9. Subject has a history of papillary conjunctivitis that has interfered with contact lens wear.
10. Subject has a history of herpetic keratitis retinal detachment or irregular cornea.
11. Subject has a history of recurrent eye or eyelid infections, adverse effects associated with your contact lens wear, intolerance or unusual response to your contact lens wear.
12. The subject has over grade II corneal and conjunctival staining (Oxford scheme) if who has a history of dry eye.
13. Subject had any corneal surgery (e.g., refractive surgery).

Primary outcomes:
measure: The effectiveness of corrected visual acuity
timeFrame: 3 Months
Secondary outcomes:
measure: Effectiveness of corrected visual acuity
timeFrame: 1 Week
Other outcomes:
Locations:
city: Taipei
country: Taiwan
facility: National Taiwan University Hospital
city: Taipei
country: Taiwan
facility: Tri-Service General Hospital
city: Taoyuan
country: Taiwan
facility: Linkou-Chang Gung Memorial Hospital
Study officials:
References: